Stay updated on Palbociclib in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Palbociclib in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Palbociclib in Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Results posted on 2026-02-12 with expanded primary and secondary outcomes and time frames (PFS, OS, ORR, DOR, CBR). New documents and data sections were added, including the Study Protocol and Statistical Analysis Plan PDF, PK data, PIK3CA biomarker analyses, and tumor biomarker data.
    Difference
    0.9%
    Check dated 2026-02-18T16:17:39.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a site revision tag 'Revision: v3.4.2' and removed older funding notices including 'Revision: v3.4.1' and the lapse-in-funding message. Core study content and navigation remain unchanged.
    Difference
    0.2%
    Check dated 2026-02-11T12:16:34.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding lapse notice was added at the top of the page to inform users about possible delays and NIH operation status. The Publications section was updated with a new NEJM article citation on Palbociclib for HR+/HER2+ Advanced Breast Cancer, and the page revision tag updated to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T06:52:34.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Show glossary is now displayed, and the page includes new footer/version details: 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The older items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T04:37:52.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4, which appears to be a versioning/metadata update without observable changes to study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:58:01.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Locations section updated with a broad list of U.S. sites (California, District of Columbia, Florida, Georgia, Illinois, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New Mexico, North Carolina, Ohio, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah) and the page revision is now v3.3.3. Previous 3.3.2 location entries were removed.
    Difference
    1%
    Check dated 2025-12-23T17:31:02.000Z thumbnail image

Stay in the know with updates to Palbociclib in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Palbociclib in Metastatic Breast Cancer Clinical Trial page.